MFDS — authorised 5 October 2018
- Marketing authorisation holder: LEADIANT BIOSCI INC
- Status: likely_approved
🇰🇷 Revcovi in South Korea
MFDS authorised Revcovi on 5 October 2018
Marketing authorisation
Revcovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Revcovi approved in South Korea?
Yes. MFDS authorised it on 5 October 2018.
Who is the marketing authorisation holder for Revcovi in South Korea?
LEADIANT BIOSCI INC holds the South Korean marketing authorisation.